Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 3 of 15
Myelo Therapeutics
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2013
Hold
7yr
Exit
2020
NBE Therapeutics
Boehringer Ingelheim Venture Fund
SwitzerlandSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2013
Hold
7yr
Exit
2020
Northern Biologics
Criteria Bio Ventures
Canada
Sector
Biotech
InvestorCaixa Capital Risc
Entry
2016
Hold
4yr
Exit
2020
Proteon Therapeutics
TVM Life Science Ventures
United StatesSector
Biotech
InvestorTVM Capital Life Science
Entry
2006
Hold
14yr
Exit
2020
TAAV
Columbus Innvierte Life Science Fund I
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2018
Hold
2yr
Exit
2020
Themis Bioscience
Wellington Partners Life Sciences
AustriaSector
Biotech
InvestorWellington Partners
Entry
2015
Hold
5yr
Exit
2020
Viralgen
Columbus Innvierte Life Science Fund I
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2018
Hold
2yr
Exit
2020
Alector
Dementia Discovery Fund
United StatesSector
Biotech
InvestorSV Health Managers
Entry
2016
Hold
3yr
Exit
2019
Amal Therapeutics
Boehringer Ingelheim Venture Fund
SwitzerlandSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2014
Hold
5yr
Owners
2
Exit
2019
Immunic
HTGF II
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
3yr
Owners
2
Exit
2019
Immunic Therapeutics
IBG Innovationsfonds
GermanySector
Biotech
Investorbmp Ventures AG
Entry
2016
Hold
3yr
Owners
2
Exit
2019
AB-Biotics
Inveready Biotech II
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2016
Hold
3yr
Exit
2019
Aprea Therapeutics
Rosetta Capital IV
SwedenSector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
6yr
Exit
2019
BlueRock Therapeutics
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2016
Hold
3yr
Exit
2019
Caprion Biosciences
GHO Capital Fund I LP
Canada
Sector
Biotech
InvestorGHO Capital
Entry
2016
Hold
3yr
Exit
2019
Capua BioServices
LIVIA Corporate Development
ItalySector
Biotech
InvestorLIVIA Group
Entry
2015
Hold
4yr
Exit
2019
Centogene
DPE Fund III
GermanySector
Biotech
InvestorDPE Deutsche Private Equity
Entry
2017
Hold
2yr
Exit
2019
Edesa Biotech
Inveready Biotech II
Canada
Sector
Biotech
InvestorInveready Asset Management
Entry
2017
Hold
2yr
Exit
2019
Imegen
Qualitas Growth Fund
SpainSector
Biotech
InvestorQualitas Equity Funds
Entry
2017
Hold
2yr
Exit
2019
Protagen
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2010
Hold
9yr
Exit
2019
Releasycell
BeAble Innvierte Science Equity Fund
SpainSector
Biotech
InvestorBeAble Capital
Entry
2018
Hold
1yr
Exit
2019
Tilos Therapeutics
Boehringer Ingelheim Venture Fund
United StatesSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2016
Hold
3yr
Exit
2019
Toscana Biomarkers
Fondo Toscana Innovazione
ItalySector
Biotech
InvestorSviluppo Imprese Centro Italia SGR
Entry
2009
Hold
9yr
Exit
2018
AgeX Therapeutics
KIZOO Evergreen (Balance Sheet)
United StatesSector
Biotech
InvestorKIZOO Technology Capital
Entry
2017
Hold
1yr
Exit
2018
Hybrigenics
Odyssee Venture Funds
FranceSector
Biotech
InvestorOdyssée Venture
Entry
2013
Hold
5yr
Exit
2018
Orchard Therapeutics
4BIO Ventures III
UKSector
Biotech
Investor4Bio Partners
Entry
2017
Hold
1yr
Exit
2018
Prexton Therapeutics
Ysios BioFund II Innvierte
CHSector
Biotech
InvestorYsios Capital Partners
Entry
2017
Hold
1yr
Exit
2018
Quethera
UK Innovation and Science Seed Fund
UKSector
Biotech
InvestorFuture Planet Capital
Entry
2015
Hold
3yr
Exit
2018
TiGenix
Ysios BioFund I
BE
Sector
Biotech
InvestorYsios Capital Partners
Entry
2007
Hold
11yr
Exit
2018
ViraTherapeutics
Boehringer Ingelheim Venture Fund
AustriaSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2013
Hold
5yr
Exit
2018
arGEN-X
Omnes Co-Investment
NetherlandsSector
Biotech
InvestorOmnes Capital
Entry
2009
Hold
8yr
Exit
2017
KALA BIO
Ysios BioFund I
USSector
Biotech
InvestorYsios Capital Partners
Entry
2014
Hold
3yr
Exit
2017
Rigontec
HTGF II
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2014
Hold
3yr
Owners
4
Exit
2017
Algal Scientific
Evonik Venture Capital
United StatesSector
Biotech
InvestorEvonik Venture Capital
Entry
2014
Hold
3yr
Exit
2017
Biopolis
Talde Capital II FCR
SpainSector
Biotech
InvestorTalde Gestión
Entry
2009
Hold
8yr
Exit
2017
evoxx technologies
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2013
Hold
4yr
Exit
2017
Fusion Antibodies
Co-Fund NI
United KingdomSector
Biotech
InvestorClarendon Fund Managers
Entry
2013
Hold
4yr
Exit
2017
Horizon Discovery
Parkwalk Opportunities EIS Fund
UKSector
Biotech
InvestorParkwalk Advisors
Entry
2013
Hold
4yr
Exit
2017
BRAIN Biotech
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2006
Hold
10yr
Exit
2016
Ganymed Pharmaceuticals
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2001
Hold
15yr
Owners
2
Exit
2016
Atopix Therapeutics
Wellington Partners Life Sciences
United KingdomSector
Biotech
InvestorWellington Partners
Entry
2013
Hold
3yr
Exit
2016
B.R.A.I.N. AG
Technologiefonds Hessen
GermanySector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2014
Hold
2yr
Exit
2016
BioGenes
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2003
Hold
12yr
Exit
2015
Phenex
LBBW VC Evergreen Vehicle
GermanySector
Biotech
InvestorLBBW Venture Capital
Entry
2005
Hold
10yr
Exit
2015
Pieris Pharmaceuticals
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2001
Hold
14yr
Exit
2015
SuppreMol
MIG Fonds 5
GermanySector
Biotech
InvestorMIG Capital
Entry
2007
Hold
8yr
Exit
2015
SuppreMol GmbH
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2006
Hold
9yr
Exit
2015
Cellectis
Odyssee Venture Funds
FranceSector
Biotech
InvestorOdyssée Venture
Entry
2002
Hold
12yr
Exit
2014
Pieris
Sobera Capital Fund II
United StatesSector
Biotech
InvestorSobera Capital
Entry
2013
Hold
1yr
Exit
2014
bluebird bio
TVM Life Science Ventures
United StatesSector
Biotech
InvestorTVM Capital Life Science
Entry
2004
Hold
9yr
Exit
2013